BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24283930)

  • 1. Rho kinase inhibitors: a patent review (2012 - 2013).
    Feng Y; LoGrasso PV
    Expert Opin Ther Pat; 2014 Mar; 24(3):295-307. PubMed ID: 24283930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rho kinase inhibitors: a patent review (2014 - 2016).
    Defert O; Boland S
    Expert Opin Ther Pat; 2017 Apr; 27(4):507-515. PubMed ID: 28048944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
    Dymock BW; See CS
    Expert Opin Ther Pat; 2013 Apr; 23(4):449-501. PubMed ID: 23367873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor inhibitors: a patent review (2010 - present).
    Li SN; Li HQ
    Expert Opin Ther Pat; 2014 Mar; 24(3):309-21. PubMed ID: 24387079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rho-kinase inhibitors in the management of glaucoma.
    Berrino E; Supuran CT
    Expert Opin Ther Pat; 2019 Oct; 29(10):817-827. PubMed ID: 31573364
    [No Abstract]   [Full Text] [Related]  

  • 6. The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis.
    Knipe RS; Tager AM; Liao JK
    Pharmacol Rev; 2015; 67(1):103-17. PubMed ID: 25395505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential.
    Feng Y; LoGrasso PV; Defert O; Li R
    J Med Chem; 2016 Mar; 59(6):2269-300. PubMed ID: 26486225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting RhoA/ROCK pathway in pulmonary arterial hypertension.
    Antoniu SA
    Expert Opin Ther Targets; 2012 Apr; 16(4):355-63. PubMed ID: 22449260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update.
    Arunesh GM; Shanthi E; Krishna MH; Sooriya Kumar J; Viswanadhan VN
    Expert Opin Ther Pat; 2014 Jan; 24(1):5-17. PubMed ID: 24131033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly selective Janus kinase 3 inhibitors based on a pyrrolo[2,3-d]pyrimidine scaffold: evaluation of WO2013085802.
    Norman P
    Expert Opin Ther Pat; 2014 Jan; 24(1):121-5. PubMed ID: 24147573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in the development of Rho-associated protein kinase (ROCK) inhibitors.
    Pan P; Shen M; Yu H; Li Y; Li D; Hou T
    Drug Discov Today; 2013 Dec; 18(23-24):1323-33. PubMed ID: 24076262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzothiazoles as Rho-associated kinase (ROCK-II) inhibitors.
    Yin Y; Lin L; Ruiz C; Cameron MD; Pocas J; Grant W; Schröter T; Chen W; Duckett D; Schürer S; Lograsso P; Feng Y
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6686-90. PubMed ID: 19837589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors.
    Guan R; Xu X; Chen M; Hu H; Ge H; Wen S; Zhou S; Pi R
    Eur J Med Chem; 2013; 70():613-22. PubMed ID: 24211637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel ROCK inhibitors for the treatment of pulmonary arterial hypertension.
    Shaw D; Hollingworth G; Soldermann N; Sprague E; Schuler W; Vangrevelinghe E; Duggan N; Thomas M; Kosaka T; Waters N; van Eis MJ
    Bioorg Med Chem Lett; 2014 Oct; 24(20):4812-7. PubMed ID: 25248678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, and Structure-Activity Relationships of Pyridine-Based Rho Kinase (ROCK) Inhibitors.
    Green J; Cao J; Bandarage UK; Gao H; Court J; Marhefka C; Jacobs M; Taslimi P; Newsome D; Nakayama T; Shah S; Rodems S
    J Med Chem; 2015 Jun; 58(12):5028-37. PubMed ID: 26039570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p38α mitogen-activated protein kinase inhibitors, a patent review (2005-2011).
    Fischer S; Koeberle SC; Laufer SA
    Expert Opin Ther Pat; 2011 Dec; 21(12):1843-66. PubMed ID: 22082194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel thiazole derivatives: a patent review (2008 - 2012; Part 1).
    Leoni A; Locatelli A; Morigi R; Rambaldi M
    Expert Opin Ther Pat; 2014 Feb; 24(2):201-16. PubMed ID: 24215328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-MET kinase inhibitors: a patent review (2011 - 2013).
    Zhu K; Kong X; Zhao D; Liang Z; Luo C
    Expert Opin Ther Pat; 2014 Feb; 24(2):217-30. PubMed ID: 24266843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2015 ATVB Plenary Lecture: translational research on rho-kinase in cardiovascular medicine.
    Shimokawa H; Satoh K
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1756-69. PubMed ID: 26069233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of novel, highly active soft ROCK inhibitors.
    Boland S; Bourin A; Alen J; Geraets J; Schroeders P; Castermans K; Kindt N; Boumans N; Panitti L; Fransen S; Vanormelingen J; Stassen JM; Leysen D; Defert O
    J Med Chem; 2015 May; 58(10):4309-24. PubMed ID: 25898023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.